<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:linked-data-default="http://data-service.theglobalfund.org/api" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <iati-identifier>47045-MOZ-C-CCS</iati-identifier>
  <reporting-org ref="47045" secondary-reporter="0" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Reinforcing the National HIV and TB Response in Mozambique</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Mozambique - TB/HIV - Centro de Colabora&#xE7;&#xE3;o em Sa&#xFA;de - CCS.  This program has the following goals: Reduce new HIV infections 25% by 2025.  Reduce HIV-related deaths 30% by 2025.  Reduce the estimated percentage of child HIV infections from HIV-positive women delivering in the past 12 months to &lt;5% by 2025.  Reduce the incidence of TB (per 100,000 population) by 4% at&#xE9; 2023.  Reduce TB-related mortality (per 100,000 population) by 39% at&#xE9; 2023. The objectives of this program are: Increase the percentage of PLHIV who know their status to 95% by 2025..  Increase coverage of PLHIV on ART to 81% by 2025..  Increase viral supression among PLHIV to 73% by 2025..  Increase case notification rate of all forms of TB (per 100,000 population) from 340 in 2019 to 402 in 2023.  Sustain  treatment success rate of all forms of TB in 90%  or above.  Improve treatment success rate of RR TB and/or MDR-TB from 57% in 2019 to 70% in 2023</narrative>
  </description>
  <participating-org role="3" type="15">
   <narrative xml:lang="EN">CCM Mozambique</narrative>
  </participating-org>
  <participating-org role="4" type="15">
   <narrative xml:lang="EN">CCM Mozambique</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="EN">Centro de Colabora&#xE7;&#xE3;o em Sa&#xFA;de</narrative>
  </participating-org>
  <participating-org role="4" type="15">
   <narrative xml:lang="EN">Centro de Colabora&#xE7;&#xE3;o em Sa&#xFA;de</narrative>
  </participating-org>
  <participating-org ref="47045" role="1" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </participating-org>
  <other-identifier ref="MOZ-C-CCS" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <other-identifier ref="b877221d-6177-406d-a247-a487b14fa96e" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2017-08-28" type="1"></activity-date>
  <activity-date iso-date="2017-08-28" type="2"></activity-date>
  <activity-date iso-date="2023-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="4">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Kirsi VIISAINEN</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>kirsi.viisainen@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="3">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Kirsi VIISAINEN</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>kirsi.viisainen@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="MZ" percentage="100">
   <narrative xml:lang="EN">Mozambique</narrative>
  </recipient-country>
  <sector code="13040" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">TB/HIV</narrative>
  </sector>
  <country-budget-items vocabulary="4">
   <budget-item code="0E92B28E-6628-4A93-91F4-24A0E3F68B43" percentage="7.34" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Communication Material and Publications (CMP)</narrative>
    </description>
   </budget-item>
   <budget-item code="C7B597A0-B5A0-4104-8A99-BA94F1C26180" percentage="2.35" vocabulary="4">
    <description>
     <narrative xml:lang="EN">External Professional services (EPS)</narrative>
    </description>
   </budget-item>
   <budget-item code="B035C5CE-BA09-412B-B386-BB992AA6A20F" percentage="0.41" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Non-Pharmaceuticals (HPNP)</narrative>
    </description>
   </budget-item>
   <budget-item code="AEEC85E4-0556-495F-8F31-584DD9FF4EF3" percentage="59.16" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Human Resources (HR)</narrative>
    </description>
   </budget-item>
   <budget-item code="400CEE75-C251-4A85-AA43-BD93DF71A408" percentage="9.84" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Indirect and Overhead Costs</narrative>
    </description>
   </budget-item>
   <budget-item code="FDEDB289-7073-424F-8780-856D2FB8F704" percentage="0.73" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Infrastructure (INF)</narrative>
    </description>
   </budget-item>
   <budget-item code="2C35AA6C-5E80-4406-B78F-58398CFB1668" percentage="2" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Living support to client/ target population (LSCTP)</narrative>
    </description>
   </budget-item>
   <budget-item code="8FF157DA-C279-44D8-8148-6161B33C9E92" percentage="3.55" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Non-health equipment (NHP)</narrative>
    </description>
   </budget-item>
   <budget-item code="F4B643AF-C501-4424-B4BD-74AA0DA9F006" percentage="14.62" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Travel related costs (TRC)</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2018-01-01"></period-start>
   <period-end iso-date="2018-03-31"></period-end>
   <value currency="USD" value-date="2018-01-01">856712</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2018-04-01"></period-start>
   <period-end iso-date="2018-06-30"></period-end>
   <value currency="USD" value-date="2018-01-01">719499</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2018-07-01"></period-start>
   <period-end iso-date="2018-09-30"></period-end>
   <value currency="USD" value-date="2018-01-01">829875</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2018-10-01"></period-start>
   <period-end iso-date="2018-12-31"></period-end>
   <value currency="USD" value-date="2018-01-01">2332262</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-03-31"></period-end>
   <value currency="USD" value-date="2018-01-01">894459</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2019-04-01"></period-start>
   <period-end iso-date="2019-06-30"></period-end>
   <value currency="USD" value-date="2018-01-01">2876780</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2019-07-01"></period-start>
   <period-end iso-date="2019-09-30"></period-end>
   <value currency="USD" value-date="2018-01-01">3951169</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2019-10-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2018-01-01">3951169</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-03-31"></period-end>
   <value currency="USD" value-date="2018-01-01">3527330</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-04-01"></period-start>
   <period-end iso-date="2020-06-30"></period-end>
   <value currency="USD" value-date="2018-01-01">3872096</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-07-01"></period-start>
   <period-end iso-date="2020-09-30"></period-end>
   <value currency="USD" value-date="2018-01-01">3348941</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-10-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2018-01-01">3212603</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-03-31"></period-end>
   <value currency="USD" value-date="2021-01-01">4816350</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-04-01"></period-start>
   <period-end iso-date="2021-06-30"></period-end>
   <value currency="USD" value-date="2021-01-01">5573842</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-07-01"></period-start>
   <period-end iso-date="2021-09-30"></period-end>
   <value currency="USD" value-date="2021-01-01">5269579</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-10-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2021-01-01">4671283</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-03-31"></period-end>
   <value currency="USD" value-date="2021-01-01">6712437</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-04-01"></period-start>
   <period-end iso-date="2022-06-30"></period-end>
   <value currency="USD" value-date="2021-01-01">5023261</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-07-01"></period-start>
   <period-end iso-date="2022-09-30"></period-end>
   <value currency="USD" value-date="2021-01-01">4555051</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-10-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2021-01-01">4499173</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-01-01"></period-start>
   <period-end iso-date="2023-03-31"></period-end>
   <value currency="USD" value-date="2021-01-01">4620796</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-04-01"></period-start>
   <period-end iso-date="2023-06-30"></period-end>
   <value currency="USD" value-date="2021-01-01">4516686</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-07-01"></period-start>
   <period-end iso-date="2023-09-30"></period-end>
   <value currency="USD" value-date="2021-01-01">4246172</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-10-01"></period-start>
   <period-end iso-date="2023-12-31"></period-end>
   <value currency="USD" value-date="2021-01-01">4665478</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="c342fc89-f2c8-4f20-b788-9f875228d068">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-12-19"></transaction-date>
   <value currency="USD" value-date="2017-12-19">12791912.81</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to MOZ-C-CCS.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centro de Colabora&#xE7;&#xE3;o em Sa&#xFA;de</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="c14fc9c9-2895-4a13-97d4-01c5a31403bd">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-06-03"></transaction-date>
   <value currency="USD" value-date="2019-06-03">-3853578.64</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to MOZ-C-CCS.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centro de Colabora&#xE7;&#xE3;o em Sa&#xFA;de</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="750394f9-31f3-4144-9ecd-0c1d983ed52c">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-06-03"></transaction-date>
   <value currency="USD" value-date="2019-06-03">13706605.15</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to MOZ-C-CCS.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centro de Colabora&#xE7;&#xE3;o em Sa&#xFA;de</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="a418e35f-3765-4835-9924-e9c298695175">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-07-22"></transaction-date>
   <value currency="USD" value-date="2020-07-22">-286338.06</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to MOZ-C-CCS.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centro de Colabora&#xE7;&#xE3;o em Sa&#xFA;de</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="6f95d6a1-f4c0-4f50-85f9-5f6016291a6e">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-07-22"></transaction-date>
   <value currency="USD" value-date="2020-07-22">7936512.15</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to MOZ-C-CCS.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centro de Colabora&#xE7;&#xE3;o em Sa&#xFA;de</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="3a536e69-09c9-4573-8b61-2cb0d409eccd">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-02-13"></transaction-date>
   <value currency="USD" value-date="2021-02-13">32066756.2</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to MOZ-C-CCS.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centro de Colabora&#xE7;&#xE3;o em Sa&#xFA;de</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="16c9e448-4589-42ae-a2ba-1eda75139166">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-12-20"></transaction-date>
   <value currency="USD" value-date="2017-12-20">1741128</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to MOZ-C-CCS.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centro de Colabora&#xE7;&#xE3;o em Sa&#xFA;de</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="a8c5f49f-e62c-4e43-9eaf-ffa3c7e66bf6">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-04-11"></transaction-date>
   <value currency="USD" value-date="2018-04-11">2785190</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to MOZ-C-CCS.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centro de Colabora&#xE7;&#xE3;o em Sa&#xFA;de</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="f01e947f-1dcc-4b82-806e-065621737725">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-12-11"></transaction-date>
   <value currency="USD" value-date="2018-12-11">1601058.17</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to MOZ-C-CCS.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centro de Colabora&#xE7;&#xE3;o em Sa&#xFA;de</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="e1a4cdc2-6c83-4449-9828-afcc4f12b338">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-26"></transaction-date>
   <value currency="USD" value-date="2019-03-26">2810958</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to MOZ-C-CCS.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centro de Colabora&#xE7;&#xE3;o em Sa&#xFA;de</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="7913d33d-4c8a-4c15-bed9-331271bd693e">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-04"></transaction-date>
   <value currency="USD" value-date="2019-06-04">4092659</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to MOZ-C-CCS.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centro de Colabora&#xE7;&#xE3;o em Sa&#xFA;de</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="49046ec6-6d82-4363-8c32-ab678d6ebadb">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-10-29"></transaction-date>
   <value currency="USD" value-date="2019-10-29">3785536</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to MOZ-C-CCS.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centro de Colabora&#xE7;&#xE3;o em Sa&#xFA;de</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="9c927735-8424-4417-9778-ef80a38218a2">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-13"></transaction-date>
   <value currency="USD" value-date="2020-02-13">5542072.09</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to MOZ-C-CCS.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centro de Colabora&#xE7;&#xE3;o em Sa&#xFA;de</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="dd576e45-34ff-41ad-88d6-89904b4b2236">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-29"></transaction-date>
   <value currency="USD" value-date="2020-07-29">6136225</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to MOZ-C-CCS.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centro de Colabora&#xE7;&#xE3;o em Sa&#xFA;de</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="f5c600e1-722f-4d70-bb32-803c640ad513">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-10-21"></transaction-date>
   <value currency="USD" value-date="2020-10-21">1800287.15</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to MOZ-C-CCS.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centro de Colabora&#xE7;&#xE3;o em Sa&#xFA;de</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="cfee9b89-35d0-4091-a585-8a6337ddcb5c">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-19"></transaction-date>
   <value currency="USD" value-date="2021-02-19">6027559.2</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to MOZ-C-CCS.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centro de Colabora&#xE7;&#xE3;o em Sa&#xFA;de</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="2326dc01-7c51-4294-bd23-ecfba48700bd">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-16"></transaction-date>
   <value currency="USD" value-date="2021-06-16">6557917.2</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to MOZ-C-CCS.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centro de Colabora&#xE7;&#xE3;o em Sa&#xFA;de</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="f8d2c449-05cc-4aa4-9e7f-48c60f91ce48">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-28"></transaction-date>
   <value currency="USD" value-date="2021-10-28">7894560</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to MOZ-C-CCS.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centro de Colabora&#xE7;&#xE3;o em Sa&#xFA;de</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="fa272db6-98d9-4d6d-aa4e-1b7192776322">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-01-27"></transaction-date>
   <value currency="USD" value-date="2022-01-27">1721630.44</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to MOZ-C-CCS.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centro de Colabora&#xE7;&#xE3;o em Sa&#xFA;de</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="c424faa5-0146-44f3-a456-9c49f9a02612">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-01-27"></transaction-date>
   <value currency="USD" value-date="2022-01-27">2558163.62</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to MOZ-C-CCS.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Centro de Colabora&#xE7;&#xE3;o em Sa&#xFA;de</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Coverage / Output indicator for MOZ-C-CCS</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
    </title>
    <baseline year="2016">
     <dimension name="HIV test status" value="Positive"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 13279</narrative>
     </comment>
    </baseline>
    <baseline year="2016">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 13399</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="TB case definition" value="Bacteriologically confirmed"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 14208</narrative>
     </comment>
    </baseline>
    <baseline year="2016">
     <dimension name="HIV test status" value="Negative"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 14816</narrative>
     </comment>
    </baseline>
    <baseline year="2016">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 17481</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Positive"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 18293</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 21504</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 24124</narrative>
     </comment>
    </baseline>
    <baseline year="2016">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 24369</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Negative"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 26878</narrative>
     </comment>
    </baseline>
    <baseline year="2016">
     <comment>
      <narrative xml:lang="EN">Numerator: 29841</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="&lt;15"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 40203</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 45628</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Not documented"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 457</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 5425</narrative>
     </comment>
    </baseline>
    <baseline year="2016">
     <dimension name="Age" value="&lt;15"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 6511</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
    </title>
    <baseline year="2016">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 133</narrative>
     </comment>
    </baseline>
    <baseline year="2016">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 202</narrative>
     </comment>
    </baseline>
    <baseline year="2016">
     <dimension name="Age" value="&lt;15"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 23</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 312</narrative>
     </comment>
    </baseline>
    <baseline year="2016">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 326</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="&lt;15"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 36</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 427</narrative>
     </comment>
    </baseline>
    <baseline year="2016">
     <comment>
      <narrative xml:lang="EN">Numerator: 471</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 703</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 739</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of people in contact with TB patients who began preventive therapy</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 20601.6</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 22597 Denominator: 37766 Percentage: 59.83</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
    </title>
    <baseline year="2016">
     <comment>
      <narrative xml:lang="EN">Numerator: 22682 Denominator: 26519 Percentage: 85.53</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TCP-Other(1) Number of contacts of Sputum and Genexpert positive TB patients who are evaluated for infection and disease</narrative>
    </title>
    <baseline year="2016">
     <comment>
      <narrative xml:lang="EN">Numerator: 24822</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 29455 Denominator: 37766 Percentage: 77.99</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of notified TB cases (all forms) contributed by non-national TB program providers &#x2013; community referrals</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 16948</narrative>
     </comment>
    </baseline>
    <baseline year="2016">
     <comment>
      <narrative xml:lang="EN">Numerator: 3410 Denominator: 29841 Percentage: 11.43</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 14493 Denominator: 14971 Percentage: 96.81</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 4081 Denominator: 71344 Percentage: 5.72</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
    </title>
    <baseline year="2016">
     <comment>
      <narrative xml:lang="EN">Numerator: 447.45</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 719</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TCS-Other: Number of patients in need reached through community health networks (patients lost to follow up) that are not reached through the health facility defaulter tracing mechanism</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 59059</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of confirmed RR/MDR-TB cases tested for resistance to second-line drugs</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 681 Denominator: 747 Percentage: 91.16</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of children &lt;5 in contact with TB patients who began isonizide preventive therapy</narrative>
    </title>
    <baseline year="2016">
     <comment>
      <narrative xml:lang="EN">Numerator: 7195</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TCS-Other (1): Number of patiets in need reached through community health network (patients on ART lost to follow-up) that are not reached through the health facility defaulter tracing mechanism</narrative>
    </title>
    <baseline year="2016">
     <comment>
      <narrative xml:lang="EN">Percentage: 53.50</narrative>
     </comment>
    </baseline>
   </indicator>
  </result>
  <result aggregation-status="0" type="3">
   <title>
    <narrative xml:lang="EN">Impact indicator for MOZ-C-CCS</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB/HIV mortality rate per 100,000 population</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 18</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of AIDS-related deaths per 100,000 population</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Age" value="&lt;5"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 110</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 154</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 161</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 168</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 245</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="5-14"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 26</narrative>
     </comment>
    </baseline>
    <baseline year="2016">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Text: 214.99</narrative>
     </comment>
    </baseline>
    <baseline year="2016">
     <comment>
      <narrative xml:lang="EN">Text: 244.48</narrative>
     </comment>
    </baseline>
    <baseline year="2016">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Text: 275.14</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-01-01"></period-start>
     <period-end iso-date="2019-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 220.69</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 176</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 193.1</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
     <actual>
      <dimension name="Gender | Age" value="Female 20-24"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 125.98</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
     <actual>
      <dimension name="Gender" value="Female"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 154.06</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 160.84</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
     <actual>
      <dimension name="Gender" value="Male"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 167.87</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
     <actual>
      <dimension name="Age" value="15+"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 244.5</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
     <actual>
      <dimension name="Gender | Age" value="Male 15-19"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 48.37</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
     <actual>
      <dimension name="Gender | Age" value="Female 15-19"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 54.92</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
     <actual>
      <dimension name="Gender | Age" value="Male 20-24"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 56.99</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
     <actual>
      <dimension name="Age" value="&lt;15"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 58.05</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-01-01"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 165.52</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 137</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 145</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 129</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-01-01"></period-start>
     <period-end iso-date="2023-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 137</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-07-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 129</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Estimated percentage of children newly infected with HIV from mother-to-child transmission among women living with HIV delivering in the past 12 months</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Percentage: 14.00</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 9.40</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 11.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 7.90</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-01-01"></period-start>
     <period-end iso-date="2023-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 9.40</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-07-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 7.90</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB incidence rate per 100,000 population</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 361</narrative>
     </comment>
    </baseline>
    <baseline year="2015">
     <comment>
      <narrative xml:lang="EN">Text: 551</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-01-01"></period-start>
     <period-end iso-date="2019-06-30"></period-end>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 551</narrative>
       <narrative xml:lang="EN">Target for: 2017</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 193.1</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 361</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2019-01-01"></period-start>
     <period-end iso-date="2019-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 220.69</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-01-01"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 165.52</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB mortality rate per 100,000 population</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 37</narrative>
     </comment>
    </baseline>
    <baseline year="2015">
     <comment>
      <narrative xml:lang="EN">Text: 74</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2020-07-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 115</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 19</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2019-07-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 164</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-01-01"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 63</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="2">
   <title>
    <narrative xml:lang="EN">Outcome indicator for MOZ-C-CCS</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate of RR TB and/or MDR-TB: Percentage of cases with RR and/or MDR-TB successfully treated</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 303 Denominator: 517 Percentage: 58.61</narrative>
     </comment>
    </baseline>
    <baseline year="2016">
     <comment>
      <narrative xml:lang="EN">Text: 50%</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-01-01"></period-start>
     <period-end iso-date="2019-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 444 Denominator: 741 Percentage: 59.92</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 155 Denominator: 312 Percentage: 49.68</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 642.96 Denominator: 989 Percentage: 65.01</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
     <actual>
      <dimension name="TB case definition" value="XDR TB"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 0.375</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 227 Denominator: 368 Percentage: 61.68</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-01-01"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 887 Denominator: 1267 Percentage: 70.01</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 63.04</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 67.06</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 70.05</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-07-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 67.06</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-07-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 70.05</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB treatment coverage: Percentage of new and relapse cases that were notified and treated among the estimated number of incident TB cases in the same year (all form of TB - bacteriologically confirmed plus clinically diagnosed)</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 45628 Denominator: 76047 Percentage: 60.00</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 79.20</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 83.24</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 80.40</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-07-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 83.24</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-07-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 80.40</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of people living with HIV not on ART at the end of the reporting period among people living with HIV who were either on ART at the end of the last reporting period or newly initiated on ART during the reporting period</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Percentage: 65.00</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 82.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 84.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 85.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-07-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 84.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-07-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 85.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of people living with HIV and on ART who are virologically suppressed</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Percentage: 69.00</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 84.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 87.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-07-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 87.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-07-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 340</narrative>
     </comment>
    </baseline>
    <baseline year="2016">
     <comment>
      <narrative xml:lang="EN">Text: 285</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 322.2235</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 360</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2019-07-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 307.3051</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-01-01"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 331.9864</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 400</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 416</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 437</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-07-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 416</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-07-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 437</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of adults and children with HIV, known to be on treatment 12 months after initiation of antiretroviral therapy</narrative>
    </title>
    <baseline year="2016">
     <comment>
      <narrative xml:lang="EN">Text: 63%</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-01-01"></period-start>
     <period-end iso-date="2019-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 78.00</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 23234 Denominator: 33758 Percentage: 68.83</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-06-30"></period-end>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 25221 Denominator: 36951 Percentage: 68.26</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 80.00</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
     <actual>
      <dimension name="Age" value="&lt;15"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 0.674184</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </actual>
     <actual>
      <dimension name="Age" value="15+"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 0.682563</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2018-07-01"></period-start>
     <period-end iso-date="2018-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 75.00</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 33889 Denominator: 38360 Percentage: 88.34</narrative>
     </comment>
    </baseline>
    <baseline year="2016">
     <comment>
      <narrative xml:lang="EN">Text: 88%</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-01-01"></period-start>
     <period-end iso-date="2019-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 35954 Denominator: 39949 Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 23276 Denominator: 27199 Percentage: 85.58</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 41322 Denominator: 45913 Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 26028 Denominator: 29824 Percentage: 87.27</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-01-01"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 46463 Denominator: 51626 Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-07-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-07-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
